The Stelo CGM will look similar to the one pictured here and is based on the Dexcom G7. | Photo by Victoria Song / The Verge
Year in and year out, most of the blood glucose tech you see at CES are devices that may not come out for years, if ever. That’s why it was refreshing to see Dexcom roll up to CES 2024 to talk about something a bit more tangible: its forthcoming Stelo continuous glucose monitor (CGM), a wearable sensor that provides a real-time look at your blood sugar levels. Unlike most CGMs, the Stelo is specifically designed to be an affordable option for Type 2 diabetics who don’t use insulin.
Unlike Type 1 diabetes, where a person produces little to no insulin, Type 2 diabetes is when, over time, the body either doesn’t produce enough insulin or the body becomes insulin resistant. Roughly 90 to 95 percent of all diagnosed diabetics have Type 2….
